Research / ENTG / Fundamental state Inspectable configuration
State dimensions Filing 0001101302-19-000010 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
60.55% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.10% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.16% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
15.49% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
17.29% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
46.43% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
18.88% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.64% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.10% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Mar 30, 2019 0/9 normalized Level 3 Jun 29, 2019 8/9 normalized Level 3 Sep 28, 2019 8/9 normalized Level 3 Dec 31, 2019 8/9 normalized Level 3 Mar 28, 2020 8/9 normalized Level 3 Jun 27, 2020 9/9 normalized Level 3 Sep 26, 2020 9/9 normalized Level 3 Dec 31, 2020 9/9 normalized Level 3 Apr 3, 2021 9/9 normalized Level 3 Jul 3, 2021 9/9 normalized Level 3 Oct 2, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Apr 2, 2022 9/9 normalized Level 3 Jul 2, 2022 9/9 normalized Level 3 Oct 1, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Apr 1, 2023 9/9 normalized Level 3 Jul 1, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Sep 26, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 163.23%
Current 60.55%
Delta -102.68% Capex Intensity Increased
Previous 7.00%
Current 7.10%
Delta 0.10% Cash Generation Decreased
Previous 21.11%
Current 20.16%
Delta -0.95% Growth Increased
Previous 15.34%
Current 15.49%
Delta 0.15% Inventory Pressure Decreased
Previous 66.25%
Current 17.29%
Delta -48.96% Margin Increased
Previous 45.59%
Current 46.43%
Delta 0.84% Profitability Increased
Previous 17.05%
Current 18.88%
Delta 1.82% R And D Intensity Increased
Previous 7.52%
Current 7.64%
Delta 0.12% Sbc Intensity Increased
Previous 1.05%
Current 1.10%
Delta 0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.